Allergan reports third quarter sales increase, responds to Valeant letter

Allergan has announced operating results for the quarter ended Sept. 30 and the declaration of a third-quarter dividend of $0.05 per share, payable on Dec.11 to stockholders on record as of Nov. 20, according to a company press release.A 17.2% increase was seen in total product net sales at $1,790.7 million compared with total product net sales in the third quarter of 2013. Within this area, total specialty pharmaceuticals net sales increased 14.3%, and total core medical devices net sales increased 30.4%, according to the press release.